APO Research
Talk to an analyst

APO RESEARCH · REPORT

Methotrexate

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.

Selected research

Market Outlook & Growth Opportunities

Global Methotrexate Market Outlook and Growth Opportunities 2026

8 January 2026196 pages

Choose your research edition.

Industry ResearchMethotrexate Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Methotrexate Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Methotrexate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methotrexate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Methotrexate Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.

North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.

Read the full market overview

The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.

This report provides an overview of the global Methotrexate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Methotrexate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Methotrexate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate market size, projected growth trends, production technologies, key applications, and end-use industries.

Methotrexate Segment by Company

Teva Pharmaceutical Industries

Qualitestrx (DAVA Pharmaceuticals)

Pfizer (Hospira)

Roxane Laboratories

Sine

Maoxiang

LingNan Pharmaceutical

Powerdone

Huiyu

Methotrexate Segment by Type

Methotrexate for Injection

Methotrexate Tablets

Methotrexate Segment by Application

Used for Cancers

Used for Rheumatoid Arthritis

Used for Other Diseases

Methotrexate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Methotrexate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Methotrexate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Methotrexate significant trends, drivers, influence factors in global and regions.

6. To analyze Methotrexate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Methotrexate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Methotrexate industry.

Chapter 3: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Methotrexate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Methotrexate Industry Trends Table 2. Methotrexate Industry Drivers Table 3. Methotrexate Industry Opportunities and Challenges Table 4. Methotrexate Industry Restraints Table 5. Global Methotrexate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Methotrexate Revenue Share by Company (2021-2026) Table 7. Global Methotrexate Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Methotrexate Sales Volume Share by Company (2021-2026) Table 9. Global Methotrexate Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Methotrexate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Methotrexate Key Company Manufacturing Base & Headquarters Table 12. Global Methotrexate Company, Product Type & Application Table 13. Global Methotrexate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Methotrexate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Methotrexate for Injection Table 18. Significant Companies of Methotrexate Tablets Table 19. Global Methotrexate Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Methotrexate Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Methotrexate Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Methotrexate Sales Volume Share by Type (2021-2026) Table 23. Global Methotrexate Sales Volume Share by Type (2027-2032) Table 24. Global Methotrexate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Methotrexate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Methotrexate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Methotrexate Sales Value Share by Type (2021-2026) Table 28. Global Methotrexate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Used for Cancers Table 30. Significant Companies of Used for Rheumatoid Arthritis Table 31. Significant Companies of Used for Other Diseases Table 32. Global Methotrexate Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Methotrexate Sales Volume by Application (2021-2026) & (Kg) Table 34. Global Methotrexate Sales Volume by Application (2027-2032) & (Kg) Table 35. Global Methotrexate Sales Volume Share by Application (2021-2026) Table 36. Global Methotrexate Sales Volume Share by Application (2027-2032) Table 37. Global Methotrexate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Methotrexate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Methotrexate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Methotrexate Sales Value Share by Application (2021-2026) Table 41. Global Methotrexate Sales Value Share by Application (2027-2032) Table 42. Global Methotrexate Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Methotrexate Sales by Region (2021-2026) & (Kg) Table 44. Global Methotrexate Sales Market Share by Region (2021-2026) Table 45. Global Methotrexate Sales by Region (2027-2032) & (Kg) Table 46. Global Methotrexate Sales Market Share by Region (2027-2032) Table 47. Global Methotrexate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Methotrexate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Methotrexate Sales Value Share by Region (2021-2026) Table 50. Global Methotrexate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Methotrexate Sales Value Share by Region (2027-2032) Table 52. Global Methotrexate Market Average Price (USD/Kg) by Region (2021-2026) Table 53. Global Methotrexate Market Average Price (USD/Kg) by Region (2027-2032) Table 54. Global Methotrexate Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. Global Methotrexate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Methotrexate Sales by Country (2021-2026) & (Kg) Table 57. Global Methotrexate Sales Market Share by Country (2021-2026) Table 58. Global Methotrexate Sales by Country (2027-2032) & (Kg) Table 59. Global Methotrexate Sales Market Share by Country (2027-2032) Table 60. Global Methotrexate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Methotrexate Sales Value Market Share by Country (2021-2026) Table 62. Global Methotrexate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Methotrexate Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Methotrexate Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Qualitestrx (DAVA Pharmaceuticals) Company Information Table 70. Qualitestrx (DAVA Pharmaceuticals) Business Overview Table 71. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 72. Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio Table 73. Qualitestrx (DAVA Pharmaceuticals) Recent Development Table 74. Pfizer (Hospira) Company Information Table 75. Pfizer (Hospira) Business Overview Table 76. Pfizer (Hospira) Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 77. Pfizer (Hospira) Methotrexate Product Portfolio Table 78. Pfizer (Hospira) Recent Development Table 79. Roxane Laboratories Company Information Table 80. Roxane Laboratories Business Overview Table 81. Roxane Laboratories Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 82. Roxane Laboratories Methotrexate Product Portfolio Table 83. Roxane Laboratories Recent Development Table 84. Sine Company Information Table 85. Sine Business Overview Table 86. Sine Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 87. Sine Methotrexate Product Portfolio Table 88. Sine Recent Development Table 89. Maoxiang Company Information Table 90. Maoxiang Business Overview Table 91. Maoxiang Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 92. Maoxiang Methotrexate Product Portfolio Table 93. Maoxiang Recent Development Table 94. LingNan Pharmaceutical Company Information Table 95. LingNan Pharmaceutical Business Overview Table 96. LingNan Pharmaceutical Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 97. LingNan Pharmaceutical Methotrexate Product Portfolio Table 98. LingNan Pharmaceutical Recent Development Table 99. Powerdone Company Information Table 100. Powerdone Business Overview Table 101. Powerdone Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 102. Powerdone Methotrexate Product Portfolio Table 103. Powerdone Recent Development Table 104. Huiyu Company Information Table 105. Huiyu Business Overview Table 106. Huiyu Methotrexate Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 107. Huiyu Methotrexate Product Portfolio Table 108. Huiyu Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Methotrexate Distributors List Table 112. Methotrexate Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Methotrexate Product Image Figure 2. Global Methotrexate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Methotrexate Sales (2021-2032) & (Kg) Figure 5. Global Methotrexate Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Methotrexate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methotrexate for Injection Image Figure 10. Methotrexate Tablets Image Figure 11. Global Methotrexate Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Methotrexate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Methotrexate Sales Volume Share by Type (2021-2032) Figure 14. Global Methotrexate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Methotrexate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Methotrexate Sales Value Share by Type (2021-2032) Figure 17. Used for Cancers Image Figure 18. Used for Rheumatoid Arthritis Image Figure 19. Used for Other Diseases Image Figure 20. Global Methotrexate Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Methotrexate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Methotrexate Sales Volume Share by Application (2021-2032) Figure 23. Global Methotrexate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Methotrexate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Methotrexate Sales Value Share by Application (2021-2032) Figure 26. Global Methotrexate Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global Methotrexate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Methotrexate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Methotrexate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Methotrexate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Methotrexate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Methotrexate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Methotrexate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Methotrexate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Methotrexate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Methotrexate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Methotrexate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Methotrexate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Methotrexate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Methotrexate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Methotrexate for Injection
  • Methotrexate Tablets
Applications
  • Used for Cancers
  • Used for Rheumatoid Arthritis
  • Used for Other Diseases
Companies covered
  • Teva Pharmaceutical Industries
  • Qualitestrx (DAVA Pharmaceuticals)
  • Pfizer (Hospira)
  • Roxane Laboratories
  • Sine
  • Maoxiang
  • LingNan Pharmaceutical
  • Powerdone
  • Huiyu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Methotrexate Sales Value (2021-2032)
  4. 1.2.2 Global Methotrexate Sales Volume (2021-2032)
  5. 1.2.3 Global Methotrexate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Methotrexate Market Dynamics
  1. 2.1 Methotrexate Industry Trends
  2. 2.2 Methotrexate Industry Drivers
  3. 2.3 Methotrexate Industry Opportunities and Challenges
  4. 2.4 Methotrexate Industry Restraints
3 Methotrexate Market by Company
  1. 3.1 Global Methotrexate Company Revenue Ranking in 2025
  2. 3.2 Global Methotrexate Revenue by Company (2021-2026)
  3. 3.3 Global Methotrexate Sales Volume by Company (2021-2026)
  4. 3.4 Global Methotrexate Average Price by Company (2021-2026)
  5. 3.5 Global Methotrexate Company Ranking (2024-2026)
  6. 3.6 Global Methotrexate Company Manufacturing Base and Headquarters
  7. 3.7 Global Methotrexate Company Product Type and Application
  8. 3.8 Global Methotrexate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Methotrexate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Methotrexate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Methotrexate Market by Type
  1. 4.1 Methotrexate Type Introduction
  2. 4.1.1 Methotrexate for Injection
  3. 4.1.2 Methotrexate Tablets
  4. 4.2 Global Methotrexate Sales Volume by Type
  5. 4.2.1 Global Methotrexate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Methotrexate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Methotrexate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Methotrexate Sales Value by Type
  9. 4.3.1 Global Methotrexate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Methotrexate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Methotrexate Sales Value Share by Type (2021-2032)
5 Methotrexate Market by Application
  1. 5.1 Methotrexate Application Introduction
  2. 5.1.1 Used for Cancers
  3. 5.1.2 Used for Rheumatoid Arthritis
  4. 5.1.3 Used for Other Diseases
  5. 5.2 Global Methotrexate Sales Volume by Application
  6. 5.2.1 Global Methotrexate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Methotrexate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Methotrexate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Methotrexate Sales Value by Application
  10. 5.3.1 Global Methotrexate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Methotrexate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Methotrexate Sales Value Share by Application (2021-2032)
6 Methotrexate Regional Sales and Value Analysis
  1. 6.1 Global Methotrexate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Methotrexate Sales by Region (2021-2032)
  3. 6.2.1 Global Methotrexate Sales by Region: 2021-2026
  4. 6.2.2 Global Methotrexate Sales by Region (2027-2032)
  5. 6.3 Global Methotrexate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Methotrexate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Methotrexate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Methotrexate Sales Value by Region (2027-2032)
  9. 6.5 Global Methotrexate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Methotrexate Sales Value (2021-2032)
  12. 6.6.2 North America Methotrexate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Methotrexate Sales Value (2021-2032)
  15. 6.7.2 Europe Methotrexate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Methotrexate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Methotrexate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Methotrexate Sales Value (2021-2032)
  21. 6.9.2 South America Methotrexate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Methotrexate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Methotrexate Sales Value Share by Country, 2025 VS 2032
7 Methotrexate Country-level Sales and Value Analysis
  1. 7.1 Global Methotrexate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Methotrexate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Methotrexate Sales by Country (2021-2032)
  4. 7.3.1 Global Methotrexate Sales by Country (2021-2026)
  5. 7.3.2 Global Methotrexate Sales by Country (2027-2032)
  6. 7.4 Global Methotrexate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Methotrexate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Methotrexate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Methotrexate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Methotrexate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Methotrexate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Methotrexate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Methotrexate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Methotrexate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Methotrexate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Methotrexate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Methotrexate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Methotrexate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Methotrexate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Methotrexate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Methotrexate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Methotrexate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Methotrexate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Methotrexate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Methotrexate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Methotrexate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Methotrexate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Methotrexate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Methotrexate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Methotrexate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Methotrexate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Methotrexate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Methotrexate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Methotrexate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Methotrexate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Methotrexate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Methotrexate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Methotrexate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Methotrexate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Methotrexate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Methotrexate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Methotrexate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Methotrexate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Methotrexate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Methotrexate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Methotrexate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Methotrexate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Methotrexate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Methotrexate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Methotrexate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Methotrexate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Methotrexate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Methotrexate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Methotrexate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Methotrexate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Methotrexate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Methotrexate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Methotrexate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Methotrexate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Methotrexate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Methotrexate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Methotrexate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Methotrexate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Methotrexate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Methotrexate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Methotrexate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Methotrexate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Methotrexate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Methotrexate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Methotrexate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Methotrexate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Methotrexate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Methotrexate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Methotrexate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Methotrexate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Methotrexate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Methotrexate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Methotrexate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Methotrexate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Methotrexate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Methotrexate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Methotrexate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Methotrexate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Methotrexate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Methotrexate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Methotrexate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Methotrexate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Methotrexate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Methotrexate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Methotrexate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Methotrexate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Methotrexate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Qualitestrx (DAVA Pharmaceuticals)
  8. 8.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
  9. 8.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
  10. 8.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
  12. 8.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
  13. 8.3 Pfizer (Hospira)
  14. 8.3.1 Pfizer (Hospira) Company Information
  15. 8.3.2 Pfizer (Hospira) Business Overview
  16. 8.3.3 Pfizer (Hospira) Methotrexate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
  18. 8.3.5 Pfizer (Hospira) Recent Developments
  19. 8.4 Roxane Laboratories
  20. 8.4.1 Roxane Laboratories Company Information
  21. 8.4.2 Roxane Laboratories Business Overview
  22. 8.4.3 Roxane Laboratories Methotrexate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roxane Laboratories Methotrexate Product Portfolio
  24. 8.4.5 Roxane Laboratories Recent Developments
  25. 8.5 Sine
  26. 8.5.1 Sine Company Information
  27. 8.5.2 Sine Business Overview
  28. 8.5.3 Sine Methotrexate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sine Methotrexate Product Portfolio
  30. 8.5.5 Sine Recent Developments
  31. 8.6 Maoxiang
  32. 8.6.1 Maoxiang Company Information
  33. 8.6.2 Maoxiang Business Overview
  34. 8.6.3 Maoxiang Methotrexate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Maoxiang Methotrexate Product Portfolio
  36. 8.6.5 Maoxiang Recent Developments
  37. 8.7 LingNan Pharmaceutical
  38. 8.7.1 LingNan Pharmaceutical Company Information
  39. 8.7.2 LingNan Pharmaceutical Business Overview
  40. 8.7.3 LingNan Pharmaceutical Methotrexate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
  42. 8.7.5 LingNan Pharmaceutical Recent Developments
  43. 8.8 Powerdone
  44. 8.8.1 Powerdone Company Information
  45. 8.8.2 Powerdone Business Overview
  46. 8.8.3 Powerdone Methotrexate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Powerdone Methotrexate Product Portfolio
  48. 8.8.5 Powerdone Recent Developments
  49. 8.9 Huiyu
  50. 8.9.1 Huiyu Company Information
  51. 8.9.2 Huiyu Business Overview
  52. 8.9.3 Huiyu Methotrexate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huiyu Methotrexate Product Portfolio
  54. 8.9.5 Huiyu Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Methotrexate Value Chain Analysis
  2. 9.1.1 Methotrexate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Methotrexate Sales Mode & Process
  6. 9.2 Methotrexate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Methotrexate Distributors
  9. 9.2.3 Methotrexate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst